MRC TASK FORCE ON NIMR
Professor Colin BlakemoreMRC
Chief Executive (Chair);
Professor Alan BernsteinPresident,
Canadian Institutes of Health Research (nominated by the MRC);
Professor Kay DaviesUniversity
of OxfordMRC Council member;
Professor Dick DentonUniversity
of BristolMRC Council member;
Professor Richard FlavellChairman,
Section of Immunobiology, School of Medicine, Yale University
and Investigator, Howard Hughes Medical Institute (nominated by
Professor Peter GrussPresident,
Max Planck Society, Germany (nominated by NIMR);
Dr Robin Lovell-BadgeNIMR;
Sir Paul NursePresident, the
Rockefeller University, New York (nominated by NIMR);
Professor Steve TomlinsonVice
Chancellor, University of Wales College of Medicine, Cardiff (nominated
by the MRC).
The UK Health Departments have been invited
to provide an observer, and a secretariat will be provided by
Dr David Smith, MRC.
To make recommendations to the MRC's Council
on the future of the NIMR including:
The strategic positioning of the
NIMR's research within the MRC's overall vision and policy framework
for the future of medical research in the UK.
Consideration of and consultation
on options for the size and location of the NIMR.
Framing of the business case for
future investment in the NIMR.
Initial planning for the appointment
of a new Director of the NIMR.
The MRC's Council set some ground-rules for
the Task Force and also agreed on the importance of consultation
in its work plan. The key points were:
The Task Force will start with a
"clean sheet" regarding the future location and size
of the NIMR.
The MRC's Vision for Science and
the policy drivers and principles for support of 21st century
science articulated in the draft report from the FIS sub-committee
will provide the primary MRC backdrop for the Task Force discussions.
A programme of staff consultation
will be agreed. This will be shared with NIMR staff and their
unions. NIMR staff and their unions will be consulted formally
at key stages and a direct route will be available for them to
provide comments to the Task Force. The Director of NIMR, Sir
John Skehel, will attend meetings when appropriate.